Screening for gestational diabetes mellitus in pregnant females.

OBJECTIVES: To evaluate the applicability of the 50-g glucose challenge test as a screening test for gestational diabetes mellitus in relation to pregnancy outcomes. METHODS: A prospective study was conducted on 818 Saudi pregnant females who were randomly recruited from the Antenatal Clinics at King Abdulaziz University Hospital and New Jeddah Clinic Hospital, Jeddah. All females underwent a 50-g glucose challenge test between 24-28 weeks gestation. A result for 50-g glucose challenge test was considered positive at > 7.2 mmol/L and the female was asked to undergo a 100-g oral glucose tolerance test. The diagnosis of gestational diabetes mellitus was carried out according to the National Diabetes Data Group criteria. RESULTS: A total of 289 females exhibited plasma glucose level > 7.2 mmol/L following the 50-g glucose challenge test. Of the 289 females enrolled for the 100-g oral glucose tolerance test, 102 were diagnosed to have gestational diabetes mellitus (positive oral glucose tolerance test) and 187 were considered oral glucose tolerance test negative according to the National Diabetes Data Group diagnostic criteria. This gave a prevalence of gestational diabetes mellitus of 12.5%. Gestational diabetes mellitus females were significantly older in age, heavier in weight, with higher gravidity, greater percentage of operative deliveries and still-births, and heavier fetal birth weight as compared with the non-gestational diabetes mellitus group (P<0.05 in each case). The maximum sensitivity and specificity of the 50-g glucose challenge test were found to be at plasma glucose value of 7.8 mmol/L post the 50g glucose load. The sensitivity and specificity of this value was 88% and 84%, with a positive predictive value of 82%. To determine whether the values of plasma glucose after a 50-g glucose load were detecting abnormalities similar to those detected according to that of oral glucose tolerance test; the values obtained one-hour post the 50-g glucose challenge test were compared with zero-, one-, 2- and 3-hour values and also the area under the curve in the 100-g oral glucose tolerance test. Plasma glucose post the 50-g glucose challenge test showed marked correlation with oral glucose tolerance test results. This was mostly occurring at the one- and 2-hour oral glucose tolerance test values and was stronger in the gestational diabetes mellitus group and in both the gestational diabetes mellitus plus negative oral glucose tolerance test combined, than in the negative oral glucose tolerance test group on its own. CONCLUSION: It is concluded that plasma glucose level measured one-hour post a 50-g glucose challenge test at 24-28 weeks of gestation with a cut-off value of 7.8 mmol/L is a reliable screening test for gestational diabetes mellitus in the local population studied. This test offers the best combination of ease and economy of use and reproducibility in screening for gestational diabetes mellitus.

Neonatal tetanus in rural and displaced communities in the East Nile Province.

A retrospective neonatal tetanus survey was conducted among rural and displaced communities in the East Nile Province in the Sudan. The results showed that neonatal tetanus was a major cause of neonatal mortality. The incidence in the displaced community was more than double that in the stable rural community, 7.1 and 3.2 per 1000 live births, respectively. Coverage with two doses of tetanus toxoid was about 58 per cent in both areas, with a drop-off rate of 15 per cent. Making use of missed opportunities to vaccinate regular attendants of antenatal care services would have increased coverage in both areas. Wrong beliefs and attitudes towards tetanus toxoid were detected among schoolgirls and teachers in the two areas.

The prevalence of endemic goitre in Kelantan, Malaysia.

A large-scale study was undertaken in the state of Kelantan, to determine the prevalence of goitre. A total of 2,450 subjects above the age of 15 years were selected from 31 localities in the state and examination for goitre was done using the technique of Perez. The state was divided into 3 areas--coastal area (area 1), inland area (area 2) and the area in between the coast and the inland area (area 3). The overall prevalence of goitre was 36.8% and the prevalence in areas 1, 2 and 3 were 23.0%, 35.9% and 44.9% respectively and ranged from 6.9% in a locality in area 1 to 59.7% in a locality in area 3. In all areas, the prevalence was higher in females than in males. The prevalence of grades I, II and III goitres were 21.5%, 1.0% and 0.5% respectively in area 1, 33.6%, 1.5% and 0.7% respectively in area 2 and 41.7%, 2.2% and 1.0% respectively in area 3. Amongst age groups, goitre prevalence was highest in the 36 to 45 years age group in area 1 (33.9%), in the 15 to 25 years age group in area 2 (39.6%) and in the 26 to 35 years age group in area 3 (54.3%). In all the areas, goitre prevalence was lowest in the above 56 years age group. We concluded that the prevalence of goitre was high in Kelantan and there were regional differences in the prevalence rate within the state.

Comparison of the efficacy of single and multiple regimens of carbimazole in the treatment of thyrotoxicosis.

Carbimazole, in 3 divided daily doses, is commonly prescribed for the treatment of thyrotoxicosis. However, based on its long intra-thyroid half-life, the drug may be effective when used as a single or twice daily dose. This study was undertaken to determine the effect of once, twice or thrice daily doses of carbimazole on thyroid function in patients with thyrotoxicosis. Seventy previously untreated thyrotoxic patients were randomly allocated to receive carbimazole 30 mg once (group 1), 15 mg twice (group 2) and 10 mg thrice (group 3) daily. All patients were also prescribed propranolol 20 mg thrice daily for the first 4 weeks. Blood was taken for total T3, T4, TSH, blood counts and liver enzymes determinations at the beginning and at 6 weeks of treatment. Only 48 (68.6%) patients were included in the analysis, as the rest defaulted follow-up (20.0%) or blood samples were not available at review (11.4%). Of the 48 patients, 17 were in group 1, 16 in group 2 and 15 in group 3. Following 6 weeks of treatment, there was no significant difference in the mean serum levels of total T3 and T4 between the 3 groups. However, there was a significant decrease in the mean serum levels of total T3 and T4 as compared to the start of the treatment. Four patients (23.5%) in group 1, 4 patients (25%) in group 2 and 3 patients (20%) in group 3 were still thyrotoxic at 6 weeks of treatment, whilst 10 patients (58.8%) in group 1, 6 patients (37.5%) in group 2 and 3 (20%) in group 3 were biochemically hypothyroid.(ABSTRACT TRUNCATED AT 250 WORDS)